Sluggish sales at its largest businesses. A need to grow faster than the industry and gain more market share. Pressure to move into more rapidly growing niches. Boston Scientific Corp.’s CEO since November, Mike Mahoney, outlined the challenges on Tuesday. He forecast the company’s core markets will stabilize this year and grow 2 percent in 2015 and 4 percent in 2017. The stock had been rising since December but fell 0.6 percent on Tuesday and 1.8 percent on Wednesday.
Boston Scientific slips a second day
February 14, 2013
Read it all, now.
Don't miss any of your favorite stories again. Read the stories that matter to you as much as you want, whenever you want when you subscribe to BostonGlobe.com.
Get full access today for just 99¢